Literature DB >> 23731910

The effectiveness of habit reversal therapy in the treatment of Tourette syndrome and other chronic tic disorders: a systematic review.

Neeladri Dutta1, Andrea E Cavanna.   

Abstract

Tourette syndrome (TS) is a neurodevelopmental disorder characterized by multiple tics, which can require active intervention. It is recognized that behavioral techniques, especially habit reversal therapy (HRT), can offer an effective alternative or complement to pharmacotherapy in this setting. We conducted a systematic literature review to evaluate the efficacy of HRT in TS and other chronic tic disorders (CTDs). Our search was restricted to randomized controlled trials that used standardized diagnostic and outcome measures to compare the efficacy of HRT against a control treatment. We identified five relevant studies, which included 353 patients. Significant post-treatment reductions in tic severity scores (range: 18.3%-37.5%) were seen in the HRT groups across all studies. Current evidence suggests that HRT can significantly reduce tic severity in both adults and children with TS and other CTDs. Further head-to-head studies are needed to compare the efficacy of HRT with other behavioral interventions for tic management.

Entities:  

Mesh:

Year:  2013        PMID: 23731910      PMCID: PMC3812724     

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  17 in total

Review 1.  Habit reversal: a review of applications and variations.

Authors:  D W Woods; R G Miltenberger
Journal:  J Behav Ther Exp Psychiatry       Date:  1995-06

Review 2.  Behavioural treatments for Tourette syndrome: an evidence-based review.

Authors:  Madeleine Frank; Andrea Eugenio Cavanna
Journal:  Behav Neurol       Date:  2013       Impact factor: 3.342

3.  Habit reversal versus supportive psychotherapy in Tourette's disorder: a randomized controlled trial and predictors of treatment response.

Authors:  Thilo Deckersbach; Scott Rauch; Ulrike Buhlmann; Sabine Wilhelm
Journal:  Behav Res Ther       Date:  2005-11-02

4.  Evaluation of a cognitive-behavioural program for the management of chronic tic and habit disorders.

Authors:  K P O'Connor; M Brault; S Robillard; J Loiselle; F Borgeat; E Stip
Journal:  Behav Res Ther       Date:  2001-06

5.  Habit reversal for the treatment of Tourette syndrome.

Authors:  N H Azrin; A L Peterson
Journal:  Behav Res Ther       Date:  1988

6.  Habit-reversal: a method of eliminating nervous habits and tics.

Authors:  N H Azrin; R G Nunn
Journal:  Behav Res Ther       Date:  1973-11

7.  The Gilles de la Tourette syndrome-quality of life scale (GTS-QOL): development and validation.

Authors:  A E Cavanna; A Schrag; D Morley; M Orth; M M Robertson; E Joyce; H D Critchley; C Selai
Journal:  Neurology       Date:  2008-10-28       Impact factor: 9.910

Review 8.  The behavioral spectrum of Gilles de la Tourette syndrome.

Authors:  Andrea Eugenio Cavanna; Serena Servo; Francesco Monaco; Mary May Robertson
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

9.  Exposure with response prevention versus habit reversal in Tourettes's syndrome: a controlled study.

Authors:  Cara W J Verdellen; Ger P J Keijsers; Danielle C Cath; Cees A L Hoogduin
Journal:  Behav Res Ther       Date:  2004-05

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

View more
  19 in total

Review 1.  Tourette Syndrome: Update.

Authors:  Mark Hallett
Journal:  Brain Dev       Date:  2015-01-17       Impact factor: 1.961

2.  Retraining and control therapy for pediatric psychogenic non-epileptic seizures.

Authors:  Aaron D Fobian; Dustin M Long; Jerzy P Szaflarski
Journal:  Ann Clin Transl Neurol       Date:  2020-08-03       Impact factor: 4.511

Review 3.  Behavioral therapy for Tourette syndrome and chronic tic disorders.

Authors:  Odette Fründt; Douglas Woods; Christos Ganos
Journal:  Neurol Clin Pract       Date:  2017-04

Review 4.  Neurobiology of the Premonitory Urge in Tourette's Syndrome: Pathophysiology and Treatment Implications.

Authors:  Andrea E Cavanna; Kevin J Black; Mark Hallett; Valerie Voon
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2017-01-25       Impact factor: 2.198

Review 5.  The prevalence of tic disorders for children in China: A systematic review and meta-analysis.

Authors:  Chunsong Yang; Lingli Zhang; Ping Zhu; Cairong Zhu; Qin Guo
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

6.  The Role of Transcranial Direct Current Stimulation (tDCS) in Tourette Syndrome: A Review and Preliminary Findings.

Authors:  Valsamma Eapen; Richard Baker; Amelia Walter; Veena Raghupathy; Jordan J Wehrman; Paul F Sowman
Journal:  Brain Sci       Date:  2017-12-08

7.  Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents.

Authors:  Floyd Sallee; Eva Kohegyi; Joan Zhao; Robert McQuade; Kevin Cox; Raymond Sanchez; Alet van Beek; Margaretta Nyilas; William Carson; Roger Kurlan
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-07-07       Impact factor: 2.576

8.  Tourette syndrome and consciousness of action.

Authors:  Andrea E Cavanna; Andrea Nani
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-09-23

9.  The ONLINE-TICS Study Protocol: A Randomized Observer-Blind Clinical Trial to Demonstrate the Efficacy and Safety of Internet-Delivered Behavioral Treatment for Adults with Chronic Tic Disorders.

Authors:  Ewgeni Jakubovski; Cornelia Reichert; Annika Karch; Nadine Buddensiek; Daniel Breuer; Kirsten Müller-Vahl
Journal:  Front Psychiatry       Date:  2016-06-30       Impact factor: 4.157

Review 10.  Safety and efficacy of aripiprazole for the treatment of pediatric Tourette syndrome and other chronic tic disorders.

Authors:  Joanna H Cox; Stefano Seri; Andrea E Cavanna
Journal:  Pediatric Health Med Ther       Date:  2016-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.